Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

CDRH launches “experiential” learning program, and more regulatory updates.

You may also be interested in...



Hosting Device Reviewers? CDRH Seeks Industry, Clinical Volunteers For Experiential Training

FDA’s device center is inviting manufacturers and clinical institutions to allow reviewers to visit their facilities and observe firsthand how medical devices are designed, developed and used.

FDA Claims Short-Term Success For Pre-Market Device Reforms

With many of its 510(k) and science reforms at least partially implemented, CDRH says it is seeing tangible, positive results. The device center cites a turnaround on multiple measures of review performance following the lows of 2010.

FDA Gives Details On New Reviewer Training Program

FDA is hoping a center-wide training program for all new reviewers, launched this month, will improve the consistency of medical device pre-market reviews.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031205

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel